Kymera Therapeutics

Discovery and targeted mass spectrometry-based proteomics: Enabling technologies advancing IRAK4 protein degrader along the drug discovery pipeline into the clinic

The American Society for Mass Spectrometry (ASMS) Annual Conference, June 5-9th 2022